RSCM
AUPH icon

Rock Springs Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Rock Springs Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,179,740
Closed -$8.65M – 109
2024
Q3 		$8.65M Hold
1,179,740
– – 0.28% 70
2024
Q2 		$6.74M Buy
1,179,740
+29,393
+3% +$155K 0.2% 77
2024
Q1 		$5.76M Buy
1,150,347
+737,777
+179% +$5M 0.15% 89
2023
Q4 		$3.71M Sell
412,570
-66,970
-14% -$552K 0.09% 85
2023
Q3 		$3.73M Hold
479,540
– – 0.1% 88
2023
Q2 		$4.64M Hold
479,540
– – 0.11% 88
2023
Q1 		$5.26M Hold
479,540
– – 0.13% 86
2022
Q4 		$2.07M Sell
479,540
-586,868
-55% -$3.41M 0.05% 104
2022
Q3 		$8.02M Buy
1,066,408
+251,282
+31% +$2.18M 0.21% 87
2022
Q2 		$8.19M Buy
815,126
+44,108
+6% +$493K 0.24% 84
2022
Q1 		$9.54M Buy
771,018
+313,845
+69% +$4.85M 0.24% 83
2021
Q4 		$10.5M Sell
457,173
-156,096
-25% -$3.7M 0.24% 89
2021
Q3 		$13.6M Sell
613,269
-172,500
-22% -$2.74M 0.29% 91
2021
Q2 		$10.2M Buy
785,769
+4,200
+0.5% +$53.5K 0.2% 113
2021
Q1 		$10.1M Buy
781,569
+7,900
+1% +$115K 0.22% 115
2020
Q4 		$10.7M Buy
773,669
+1,100
+0.1% +$16K 0.23% 111
2020
Q3 		$11.4M Buy
+772,569
New +$11.2M 0.29% 93

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Rock Springs Capital Management's AUPH Position: Q4 2024 in Review

Rock Springs Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2024, closing a stake of 1,179,740 shares — an estimated $8.65M sold.

Rock Springs Capital Management first reported a position in AUPH in Q3 2020 and held it in 17 quarters. The position peaked at $13.6M in Q3 2021. 200 funds tracked by Wall St. Rank hold AUPH as of Q4 2024.

  • Rock Springs Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Rock Springs Capital Management sold 1,179,740 Aurinia Pharmaceuticals shares in Q4 2024, an estimated $8.65M.
  • Rock Springs Capital Management first reported a position in Aurinia Pharmaceuticals in Q3 2020 and held it in 17 quarters.
  • Rock Springs Capital Management's Aurinia Pharmaceuticals position peaked at $13.6M in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2024.

Based on Rock Springs Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.